Investors and industry analysts will now have to wait a little longer to learn details of Viatris’ long-term “strategic roadmap,” after the company announced that an investor event scheduled for 7 January 2022 had been delayed to “no later than 28 February when the company expects to report its fourth quarter 2021 results.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?